Antisense oligonucleotides delivered to the amniotic cavityin uteromodulate gene expression in the postnatal mouse-Reference-Cited by-同舟云学术

Antisense oligonucleotides delivered to the amniotic cavityin uteromodulate gene expression in the postnatal mouse

Published:2016-09-28 Issue: Volume: Page:gkw867
ISSN:0305-1048
Container-title:Nucleic Acids Research
language:en
Short-container-title:Nucleic Acids Res

Author:

Depreux Frederic F.,Wang Lingyan,Jiang Han,Jodelka Francine M.,Rosencrans Robert F.,Rigo Frank,Lentz Jennifer J.,Brigande John V.,Hastings Michelle L.

Publisher

Oxford University Press (OUP)

Subject

Genetics

Link

http://academic.oup.com/nar/article-pdf/44/20/9519/9598803/gkw867.pdf

Reference51 articles.

1. Stillbirths: rates, risk factors, and acceleration towards 2030

2. From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges

3. Stem cell and genetic therapies for the fetus

4. In utero therapy for congenital disorders using amniotic fluid stem cells;Ramachandra;Front. Pharmacol.,2014

5. Perinatal Gene Transfer to the Liver

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Utero Gene Therapy and its Application in Genetic Hearing Loss;Advanced Biology;2024-07-15

2. Prenatal delivery of a therapeutic antisense oligonucleotide achieves broad biodistribution in the brain and ameliorates Angelman syndrome phenotype in mice;Molecular Therapy;2024-04

3. Targeting and engineering long non-coding RNAs for cancer therapy;Nature Reviews Genetics;2024-02-29

4. Scn2a insufficiency alters spontaneous neuronal Ca2+ activity in somatosensory cortex during wakefulness;iScience;2023-11

5. Spotlight on Genetic Kidney Diseases: A Call for Drug Delivery and Nanomedicine Solutions;ACS Nano;2023-03-29